2.9(top 6%)
Impact Factor
3.3(top 6%)
extended IF
86(top 4%)
H-Index
777
authors
2.2K
papers
49.7K
citations
2.9K
citing journals
14.2K
citing authors

Most Cited Articles of Journal of Child and Adolescent Psychopharmacology

TitleYearCitations
Functional impairment in children and adolescents with obsessive-compulsive disorder2003379
DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls2002240
A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents2003224
Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version2004219
The presentation of anxiety in children with pervasive developmental disorders2005204
Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder2000189
Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents2011184
Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder2009181
Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts and hypersexuality2002180
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders2006174
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data2007173
Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations2006167
Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference2015165
A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment2008164
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder2001161
Medication patterns in patients with autism: temporal, regional, and demographic influences2005147
An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder2007146
Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders2013144
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder2009142
Calming effects of deep touch pressure in patients with autistic disorder, college students, and animals1992141
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder2006140
Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression2003140
Neurobiological substrates of Tourette's disorder2010139
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?2003138
Medication use among children with autism spectrum disorders2007136